Pfizer China

Pfizer China, established in 1989 and headquartered in Beijing, is a key pharmaceutical manufacturer specializing in the development, production, and distribution of medical and healthcare products. As part of the global Pfizer network, it focuses on scientific research and development to advance healthcare solutions across China and the Asia Pacific region. The company's operations are deeply rooted in scientific innovation, contributing to medical progress through dedicated pharmaceutical research and manufacturing.

Operating with a substantial workforce of 5,000-10,000 employees, Pfizer China manages multiple facilities across China, emphasizing research, development, and advanced manufacturing processes. This extensive operational footprint allows for the efficient production and distribution of its pharmaceutical offerings. The company's commitment extends to fostering a skilled team, and insights into its personnel can be found by Meet Pfizer China's team. Pfizer China's strategic focus on scientific rigor and operational excellence underpins its role in delivering essential healthcare products to diverse markets.

With a reported revenue of $2.4B, Pfizer China demonstrates significant economic impact and market presence. The company serves both business-to-business (B2B) and healthcare sectors throughout the Asia Pacific, playing a crucial role in regional medical advancement and public health initiatives. Its activities are supported by hashtags like #china, #asiapacific, and #asia, highlighting its geographic focus and operational scope. Pfizer China's dedication to well-being and science positions it as a key player in the pharmaceutical landscape, driving innovation and accessibility in healthcare.